Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pramipexole for Social Disconnection in Anxiety and Depression
NCT06269146Phase 2Active, not recruiting
- Sponsor
- University of California, San Diego
- Start
- May 2024
- Primary completion
- Nov 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pramipexole in anxiety disorder, major depressive disorder (MDD), sponsored by University of California, San Diego. Started May 2024; status: active, not recruiting.
02
Drugs
pramipexole
03
Conditions
anxiety disordermajor depressive disorder (MDD)
Beyond the preview
Go deeper on NCT06269146.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06269146.